Last reviewed · How we verify
NCT06666088
Cognitive Stimulation and Strength Training in Older Adults With Cognitive Impairment
NA trial testing Cognitive stimulation and Strength training in Cognitive Impairment in 81 participants. Completed in 11 April 2025.
7 April 2025
Quick facts
| Lead sponsor | University of Jaén |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 81 |
| Start date | 13 January 2025 |
| Primary completion | 7 April 2025 |
| Estimated completion | 11 April 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Cognitive stimulation and Strength training
Conditions studied
- Cognitive Impairment — all drugs for Cognitive Impairment →
Sponsor
University of Jaén
Who can join
60 and older, any sex, with Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This program focuses on integrating cognitive exercises and strength training for older adults experiencing mild cognitive impairment (MCI). It aims to enhance cognitive functions such as memory, attention, and problem-solving skills through various stimulating activities. At the same time, it incorporates strength training exercises to improve muscle mass, balance, and overall physical mobility. By addressing both cognitive and physical aspects of health, the initiative seeks to provide comprehensive benefits that may lead to improved quality of life for older adults with MCI. The research contributes valuable insights into the importance of holistic interventions in mitigating the effects of cognitive decline and promoting physical well-being in this vulnerable population.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cognitive Stimulation and Strength Training in Older Adults with Mild Cognitive Impairment: A Randomized Controlled Trial.
Muñoz-Perete JM, Carcelén-Fraile MDM, Castellote-Caballero Y, Carcelén-Fraile MDC. · · 2025 · PMID 40564798 · DOI 10.3390/diagnostics15121477
Verify or expand the search:
- PubMed search for NCT06666088
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Impairment
Currently open trials in the same condition.
- NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
- NCT07396779 — Cognitive Task-Based Walking Effects on Cognition, Mood, Sleep, and Quality of Life in Older Adults With Brain Fog · NA · active not recruiting
- NCT07084831 — A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment i · Phase 3 · recruiting
- NCT07125378 — Living Independence Through Functional Training · Phase 1, PHASE2 · recruiting
- NCT07268079 — Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality · recruiting
Other University of Jaén trials
Trials by the same sponsor.
- NCT07445113 — Diaphragmatic Breathing and Stimulation of the Autonomic Nervous System · NA · not yet recruiting
- NCT07258693 — Multimodal Treatment of Knee Osteoarthritis: Therapeutic Exercise and Noninvasive Neuromodulation (NESA) Versus Therapeu · NA · active not recruiting
- NCT07184242 — Strength Training and Proprioceptive Stimulation on Pain, Function, Quality of Life, Sleep Quality, and Psychosocial Fac · NA · completed
- NCT07041970 — PregFit Adventure: Strengthening Mothers-to-Be (PregFit) · NA · not yet recruiting
- NCT06721897 — Effectiveness of a Prehabilitation Program for Hip or Knee Arthroplasty Surgery. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06666088 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Jaén
- Last refreshed: 22 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06666088.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing